GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » Loans Receivable

S Biomedics Co (XKRX:304360) Loans Receivable : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co Loans Receivable?

S Biomedics Co's Loans Receivable for the quarter that ended in Mar. 2024 was ₩0 Mil.


S Biomedics Co Loans Receivable Historical Data

The historical data trend for S Biomedics Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co Loans Receivable Chart

S Biomedics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Loans Receivable
Get a 7-Day Free Trial - - - - -

S Biomedics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

S Biomedics Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


S Biomedics Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


S Biomedics Co (XKRX:304360) Business Description

Traded in Other Exchanges
N/A
Address
Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797
S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines